Delineating the contributions of AT1a and AT1b receptor-mediated uptake of ANG II in kidneys and adrenals.
Ortiz
Rudy M
RM
D000311:Adrenal Glands / Q000187:drug effects / Q000378:metabolism*; D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000097:blood / Q000378:metabolism*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D004705:Endocytosis; D007668:Kidney / Q000187:drug effects / Q000378:metabolism*; D051379:Mice; D018345:Mice, Knockout; D020033:Protein Isoforms / Q000502:physiology; D051381:Rats; D044140:Receptor, Angiotensin, Type 1 / Q000502:physiology*; D012964:Sodium / Q000378:metabolism; D013552:Swine
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D020033:Protein Isoforms; D044140:Receptor, Angiotensin, Type 1; D000804:Angiotensin II; D012964:Sodium